发明名称 CONCENTRATED METHOTREXATE SOLUTIONS
摘要 <p>Use of methotrexate is claimed for the preparation of parenteral medicament to treat inflammatory autoimmune disease, where the methotrexate is added to a pharmaceutically compatible solvent, in a concentration of more than 25 mg/ml. Independent claims are included for: (1) a ready-made syringe and carpule, comprising a formulation of methotrexate, which is added to a pharmaceutically compatible solvent, in a concentration of more than 25 mg/ml; and (2) a pen-injector comprising the carpule. - ACTIVITY : Antiinflammatory; Immunosuppressive; Antiarthritic; Antirheumatic; Vasotropic; Gastrointestinal-Gen; Antiulcer; Antiasthmatic; Neuroprotective; Nootropic; Antipsoriatic. - MECHANISM OF ACTION : None given.</p>
申请公布号 EP2046332(B1) 申请公布日期 2010.12.15
申请号 EP20070786239 申请日期 2007.07.20
申请人 MEDAC GESELLSCHAFT FUER KLINISCHE SPEZIALPRAEPARATE MBH 发明人 WILL, HEINER
分类号 A61K31/519;A61K9/00;A61P11/06;A61P17/06;A61P19/00;A61P19/02;A61P25/28;A61P37/00;A61P37/06 主分类号 A61K31/519
代理机构 代理人
主权项
地址